|
Loading...
| ||||||||||||||
Recent Publications by Cyclacel Limited: |  | |
| REPLACE: a strategy for iterative design of cyclin-binding groove inhibitors.
We describe a drug-design strategy termed REPLACE (REplacement with... | Cyclacel Limited, James Lindsay Place, Dundee, DD1 5JJ, UK. | Chembiochem. 2006 Dec;7(12):1909-15.
DOI Direct Link |
| Recent progress in the discovery and development of cyclin-dependent kinase inhibitors.
Cyclin-dependent kinases (CDKs) have long been known to be the main... | Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ, Scotland, UK. | Expert Opin Investig Drugs. 2005 Apr;14(4):457-77.
DOI Direct Link |
| Synthesis and biological activity of conjugates between paclitaxel and the cell delivery vector penetratin.
Synthesis of paclitaxel-penetratin (pAntp) constructs, in which the 2'- or... | Cyclacel Limited, James Lindsay Place, Dundee DD1 5JJ, Scotland, UK. | Bioorg Med Chem Lett. 2006 May 15;16(10):2628-31. Epub 2006 Mar 2.
DOI Direct Link |
| Design, synthesis, biological activity and structural analysis of cyclic peptide inhibitors targeting the substrate recruitment site of cyclin-dependent kinase complexes.
Inhibition of cyclin A- and cyclin E-associated cyclin-dependent kinase-2... | Cyclacel Limited, James Lindsay Place, Dundee, Scotland, UK. | Org Biomol Chem. 2004 Oct 7;2(19):2735-41. Epub 2004 Sep 9.
DOI Direct Link |
| Progress in the discovery of polo-like kinase inhibitors.
Polo-like kinases (PLKs) are key enzymes that control mitotic entry of... | Cyclacel Limited, James Lindsay Place, Dundee, DD1 5JJ, UK. | Curr Top Med Chem. 2005;5(2):181-97. |
Cyclacel Limited Patents: |  |
| US Patent No. | Title |
| 7427627 | N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds |
| 6852906 | Assay for measuring enzyme activity in vivo |
| 6828106 | Methods and compositions using coiled binding partners |
| 6808874 | Methods of monitoring enzyme activity |
| 6699854 | Anti-cancer compounds |